BRWM
SRPT icon

B. Riley Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

B. Riley Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-800
Closed -$24K – 657
2015
Q2 		$24K Hold
800
– – 0.02% 567
2015
Q1 		$10K Hold
800
– – 0.01% 756
2014
Q4 		$11K Sell
800
-100
-11% -$1.69K 0.01% 718
2014
Q3 		$18K Hold
900
– – 0.01% 642
2014
Q2 		$26K Buy
900
+800
+800% +$25.3K 0.02% 598
2014
Q1 		$2K Buy
+100
New +$2.55K ﹤0.01% 1013

Other funds holding SRPT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

B. Riley Wealth Management's SRPT Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Sarepta Therapeutics (SRPT) in Q3 2015, closing a stake of 800 shares — an estimated $24K sold.

B. Riley Wealth Management first reported a position in SRPT in Q1 2014 and held it in 6 quarters. The position peaked at $26K in Q2 2014. 149 funds tracked by Wall St. Rank hold SRPT as of Q3 2015.

  • B. Riley Wealth Management reported no remaining Sarepta Therapeutics position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 800 Sarepta Therapeutics shares in Q3 2015, an estimated $24K.
  • B. Riley Wealth Management first reported a position in Sarepta Therapeutics in Q1 2014 and held it in 6 quarters.
  • B. Riley Wealth Management's Sarepta Therapeutics position peaked at $26K in Q2 2014.
  • 149 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.